FDAFDA · Food and drugs·Recall number D-0339-2019
Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01
Published December 26, 2018 · Recall initiated: December 6, 2018
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- LEVOXYL
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0360793856018
- Lot
- Lot #:18A18, Exp. 01/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.